Judith Derdelinckx

5PUBLICATIONS
8CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Regenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 11, 2022
Tolerogenic Dendritic Cells Induce Apoptosis-Independent T Cell Hyporesponsiveness of SARS-CoV-2-Specific T Cells in an Antigen-Specific Manner.

Mats Van Delen, Ibo Janssens, Amber Dams

|Sep 22, 2022
Improved detection of MOG antibody-associated transverse myelitis with 18F-FDG-PET: a case report.

F Daems, J Derdelinckx, S Ceyssens

|Jul 24, 2021
Made to Measure: Patient-Tailored Treatment of Multiple Sclerosis Using Cell-Based Therapies.

Inez Wens, Ibo Janssens, Judith Derdelinckx

|Dec 22, 2020
HLA Class II Genotype Does Not Affect the Myelin Responsiveness of Multiple Sclerosis Patients.

Judith Derdelinckx, Irene Nkansah, Naomi Ooms

|Aug 17, 2019
Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA.

Judith Derdelinckx, María José Mansilla, Maxime De Laere

Pageof 1

Frequent Collaborators

2 joint publications

Tatjana Reynders

2 joint publications

Barbara Willekens

1 joint publications

F Daems

1 joint publications

S Vanden Bossche